^
Association details:
| Biomarker: | IGF1R expression |
|---|---|
| Cancer: | Thymic Carcinoma |
| Drug: | everolimus (mTOR inhibitor) |
| Direction: | Resistant |
Evidence:
Source:
Title:
Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy
Published date:
02/01/2018
Excerpt:
Patients received oral everolimus 10 mg/d...Immunohistochemical positivity for p4E-BP1 or insulin-like growth factor-1 receptor was statistically significantly related to a shorter survival.
DOI:
10.1200/JCO.2017.74.4078
Trial ID:
